AdvaMed Backs USMCA Renewal, Citing Supply Chain Stability and Medtech Export Leadership
SHERIDAN, WYOMING - April 09, 2026 - Medtech supply chains across North America depend on the continued operation of the United States-Mexico-Canada Agreement, and a formal renewal keeps tariff predictability intact for the more than 650 medtech and health tech companies that AdvaMed represents - the majority of them small businesses.
Why USMCA matters to the medtech sector
The U.S. medtech industry spans manufacturing, research and development, and global healthcare delivery. Cross-border supply chains between the United States, Mexico, and Canada underpin both domestic production and the export leadership that U.S. medtech companies hold internationally. Without a stable trilateral trade framework, manufacturers face uncertainty in sourcing components, managing regulatory timelines, and forecasting capital investments.